BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 30086361)

  • 1. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.
    He R; Shi X; Zhou M; Zhao Y; Pan S; Zhao C; Guo X; Wang M; Li X; Qin R
    Toxicol Appl Pharmacol; 2018 Oct; 356():159-171. PubMed ID: 30086361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alantolactone induces apoptosis and suppresses migration in MCF‑7 human breast cancer cells via the p38 MAPK, NF‑κB and Nrf2 signaling pathways.
    Liu J; Liu M; Wang S; He Y; Huo Y; Yang Z; Cao X
    Int J Mol Med; 2018 Oct; 42(4):1847-1856. PubMed ID: 30015828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells" [Biochem. Pharmacol. 102 (2016) 34-44].
    Zhang J; Li Y; Duan D; Yao J; Gao K; Fang J
    Biochem Pharmacol; 2024 Jul; 225():116317. PubMed ID: 38797270
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysosome biogenesis in health and disease.
    Bajaj L; Lotfi P; Pal R; Ronza AD; Sharma J; Sardiello M
    J Neurochem; 2019 Mar; 148(5):573-589. PubMed ID: 30092616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR-dependent phosphorylation controls TFEB nuclear export.
    Napolitano G; Esposito A; Choi H; Matarese M; Benedetti V; Di Malta C; Monfregola J; Medina DL; Lippincott-Schwartz J; Ballabio A
    Nat Commun; 2018 Aug; 9(1):3312. PubMed ID: 30120233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alantolactone exhibits selective antitumor effects in HELA human cervical cancer cells by inhibiting cell migration and invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis and targeting Nf-kB signalling pathway.
    Zhang Y; Zhao Y; Ran Y; Guo J; Cui H; Liu S
    J BUON; 2019; 24(6):2310-2315. PubMed ID: 31983099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFEB-driven autophagy potentiates TGF-β induced migration in pancreatic cancer cells.
    He R; Wang M; Zhao C; Shen M; Yu Y; He L; Zhao Y; Chen H; Shi X; Zhou M; Pan S; Liu Y; Guo X; Li X; Qin R
    J Exp Clin Cancer Res; 2019 Aug; 38(1):340. PubMed ID: 31387632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer.
    Zhang J; Shen L; Li X; Song W; Liu Y; Huang L
    ACS Nano; 2019 Nov; 13(11):12511-12524. PubMed ID: 31664821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells.
    Kang X; Wang H; Li Y; Xiao Y; Zhao L; Zhang T; Zhou S; Zhou X; Li Y; Shou Z; Chen C; Li B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1961-1970. PubMed ID: 31116036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
    He W; Cao P; Xia Y; Hong L; Zhang T; Shen X; Zheng P; Shen H; Zhao Y; Zou P
    Free Radic Res; 2019 Jan; 53(1):104-114. PubMed ID: 30668191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
    Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
    J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
    Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
    Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathway.
    Li X; Lu C; Liu S; Shuaishuai Liu ; Su C; Xiao T; Bi Z; Sheng P; Huang M; Liu X; Wei Y; Zhao L; Miao S; Mao J; Huang K; Gao S; Liu N; Qi M; Liu T; Qin S; Wei L; Sun T; Ning W; Yang G; Zhou H; Yang C
    Eur J Med Chem; 2018 Sep; 157():229-247. PubMed ID: 30096654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alantolactone in chrysanthemum extract.
    Contact Dermatitis; 1978 Dec; 4(6):368-9. PubMed ID: 738042
    [No Abstract]   [Full Text] [Related]  

  • 15. Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia.
    Shi C; Lan W; Wang Z; Yang D; Wei J; Liu Z; Teng Y; Gu M; Yuan T; Cao F; Zhou J; Li Y
    Cancer Cell Int; 2020; 20():442. PubMed ID: 32943990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress on antitumor mechanisms and molecular targets of Inula sesquiterpene lactones.
    Cao F; Chu C; Qin JJ; Guan X
    Chin Med; 2023 Dec; 18(1):164. PubMed ID: 38111074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of autophagy and its implications in human disease.
    Lei Y; Klionsky DJ
    Cell Death Differ; 2023 Jun; 30(6):1416-1429. PubMed ID: 37045910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin B plays a role in spermatogenesis and sperm maturation through regulating autophagy and apoptosis in mice.
    Wen Z; Zhu H; Wu B; Zhang A; Wang H; Cheng Y; Zhao H; Li J; Liu M; Gao J
    PeerJ; 2022; 10():e14472. PubMed ID: 36518274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagy in pancreatic cancer: The cancer stem cell perspective.
    Troumpoukis D; Papadimitropoulou A; Charalampous C; Kogionou P; Palamaris K; Sarantis P; Serafimidis I
    Front Oncol; 2022; 12():1049436. PubMed ID: 36505808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Small Molecules in Gastrointestinal Tract and Associated Cancers: Molecular Insights and Targeted Therapies.
    Islam F; Mitra S; Emran TB; Khan Z; Nath N; Das R; Sharma R; Awadh AAA; Park MN; Kim B
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.